Neural Stability after Retinal Detachment
视网膜脱离后的神经稳定性
基本信息
- 批准号:8238663
- 负责人:
- 金额:$ 37.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-01 至 2017-01-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAnimal ModelAxonBiochemicalBiological AssayBrain InjuriesCell Culture TechniquesCellsDataDegenerative DisorderEffectivenessElectron MicroscopyElectronsElectroretinographyElementsEyeFamily suidaeGlial Fibrillary Acidic ProteinGoalsGuanosine Triphosphate PhosphohydrolasesHourHumanImage AnalysisImmunohistochemistryIn VitroInjection of therapeutic agentInjuryLIM Domain Kinase 1LasersLightMicroscopicModificationMorphologyMuller&aposs cellMyosin Light Chain KinaseMyosin Light ChainsNeuraxisNeurogliaOperative Surgical ProceduresOutcomePatientsPharmaceutical PreparationsPhosphorylationPhosphotransferasesPhotoreceptorsPresynaptic TerminalsPreventionPublishingRecoveryRecovery of FunctionReportingRetinaRetinalRetinal ConeRetinal DetachmentRho-associated kinaseScanning Electron MicroscopySignal PathwaySignal TransductionSiteSpinal cord injuryStructureSynapsesSynaptic plasticityTestingTimeUp-RegulationVisionVisualVisual AcuityVisual system structureWestern Blottingbasecentral nervous system injurycytotoxicitydensitydesigndosagedrug testingfasudilhorizontal cellimmunocytochemistryimprovedin vivo Modellight microscopypreventrelating to nervous systemrepairedresearch studyresponse to injuryretinal neuronretinal rodsrhotherapeutic target
项目摘要
DESCRIPTION (provided by applicant): Visual recovery after repair of a retinal detachment is often disappointing with more than half of treated patients reporting below normal visual acuity. Retinal neurons undergo dramatic structural plasticity after detachment including retraction of rod axons, rounding of cone terminals, and sprouting by bipolar and horizontal cells. Some of these changes occur within hours after retinal injury in animal models. It has been suggested that this synaptic remodeling contributes to poor visual recovery. In retinal cell cultures, activation of the RhoA-Rho kinase (ROCK) signaling cascade is primarily responsible for rod axon retraction. Thus, this application tests the hypothesis that a combined therapy of RhoA-antagonists and retinal surgery may significantly improve the visual outcome after repair of a detached retina by preventing or reducing synaptic plasticity. This hypothesis will be tested on adult pigs, whose eyes are similar to human eyes, focusing on the following specific aims: 1) To test whether RhoA antagonists which inhibit the activity of RhoA, ROCK, or their substrates will prevent the structural synaptic changes caused by detachment including rod axon retraction, rod-bipolar synaptic dissolution, cone terminal morphological change, and bipolar cell sprouting. The effect on glial cell reactivity will also be examined; 2) To determine whether RhoA-related drugs can be applied after a detachment, a more therapeutically relevant scenario, and if so, how long after the injury; and 3) To determine if detached retinas treated with RhoA-related drugs indeed help visual structural and functional recovery after reattachment surgery. Morphology will be assessed by immunohistochemistry, image analysis and confocal laser scanning and electron microscopy. Levels of activity and the time-course of Rho signaling will be determined by biochemical assays for multiple components including RhoA activation and myosin light chain phosphorylation. Retinal function after reattachment will be assessed by electroretinograms. Some of the drugs that will be tested (Ct-04 and fasudil) have already been approved for human use. We hope to establish the approximate dosage and mode of application to be tested in patients, if RhoA antagonists prove to be a useful adjunct to surgical reattachment.
PUBLIC HEALTH RELEVANCE: Visual outcomes after repair of retinal detachment remain disappointing even years after successful reattachment surgery. Based on the effectiveness of preventing deleterious photoreceptor synaptic change, in vitro, a new therapy is proposed for retinal detachment. The therapy consists of intraocular application of RhoA antagonists combined with relatively rapid retinal reattachment.
描述(由申请人提供):维修视网膜脱离后的视觉恢复通常令人失望,其中一半以上的患者报告低于正常视力。视网膜神经元在脱离后会经历戏剧性的结构可塑性,包括回缩杆轴突,圆锥末端的圆形以及双极和水平细胞发芽。这些变化中的一些发生在视网膜模型的视网膜损伤后数小时内发生。已经提出,这种突触重塑有助于视觉恢复不良。在视网膜细胞培养物中,Rhoa-Rho激酶(岩石)信号级联反应的激活主要负责ROD轴突缩回。因此,该应用检验了以下假设:Rhoa抗逆邦剂和视网膜手术的联合治疗可以通过预防或降低突触可塑性来修复分离的视网膜后的视觉结果。该假设将在成年猪上进行测试,其眼睛与人眼相似,重点是以下特定目的:1)测试RhoA拮抗剂是否抑制RhoA,Rock或其底物的活性会阻止结构突触变化引起的结构变化。通过脱离,包括杆轴突缩回,杆双极突触溶解,锥末端形态变化和双极细胞发芽。还将检查对神经胶质细胞反应性的影响; 2)确定在脱离后是否可以使用与RhoA相关的药物,更具治疗性相关的情况,如果是这样,受伤后多长时间; 3)确定用RhoA相关药物处理的分离的视网膜是否确实有助于重新手术后的视觉结构和功能恢复。形态将通过免疫组织化学,图像分析和共聚焦激光扫描和电子显微镜进行评估。 RHO信号传导的活性水平和时间顺序将由多种组分(包括RhoA激活和肌球蛋白轻链磷酸化)的生化测定确定。重新计算后的视网膜功能将通过电视图评估。一些将要测试的药物(CT-04和Fasudil)已经被批准用于人类使用。如果Rhoa拮抗剂被证明是手术重新检查的有用辅助手术,我们希望建立在患者中测试的近似剂量和应用方式。
公共卫生相关性:维修视网膜超脱后的视觉结局,即使在成功进行手术手术后的几年后,视觉上仍然令人失望。基于预防有害光感受器突触变化的有效性,在体外,提出了一种新的治疗视网膜脱离疗法。该疗法由RhoA拮抗剂的眼内应用,结合了相对较快的视网膜重新连接。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELLEN S TOWNES-ANDERSON其他文献
ELLEN S TOWNES-ANDERSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELLEN S TOWNES-ANDERSON', 18)}}的其他基金
Designer Retinal Circuits: Interfacing optical tweezers with an electronic device
设计师视网膜电路:光镊与电子设备的连接
- 批准号:
7585225 - 财政年份:2008
- 资助金额:
$ 37.27万 - 项目类别:
Designer Retinal Circuits: Interfacing optical tweezers with an electronic device
设计师视网膜电路:光镊与电子设备的连接
- 批准号:
7471796 - 财政年份:2008
- 资助金额:
$ 37.27万 - 项目类别:
Designer Retinal Circuits: Interfacing optical tweezers with an electronic device
设计师视网膜电路:光镊与电子设备的连接
- 批准号:
7765166 - 财政年份:2008
- 资助金额:
$ 37.27万 - 项目类别:
Designer Retinal Circuits: Interfacing optical tweezers with an electronic device
设计师视网膜电路:光镊与电子设备的连接
- 批准号:
7922272 - 财政年份:2008
- 资助金额:
$ 37.27万 - 项目类别:
Training for Integrative Neuroscience in Health and Disease
健康与疾病综合神经科学培训
- 批准号:
7841785 - 财政年份:2007
- 资助金额:
$ 37.27万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
利用肝癌动物模型开展化学可控的在体基因编辑体系的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
- 批准号:
10603436 - 财政年份:2023
- 资助金额:
$ 37.27万 - 项目类别:
The Pain in a Dish Assay (PIDA): a high throughput system featuring human stem cell-derived nociceptors and dorsal horn neurons to test compounds for analgesic activity
皿中疼痛测定 (PIDA):一种高通量系统,具有人类干细胞来源的伤害感受器和背角神经元,用于测试化合物的镇痛活性
- 批准号:
10759735 - 财政年份:2023
- 资助金额:
$ 37.27万 - 项目类别:
A Connectomic Analysis of a Developing Brain Undergoing Neurogenesis
正在经历神经发生的发育中大脑的连接组学分析
- 批准号:
10719296 - 财政年份:2023
- 资助金额:
$ 37.27万 - 项目类别:
Anti-Aging Molecule Sirt6 in Neuroprotection in Diabetic Retina
抗衰老分子 Sirt6 对糖尿病视网膜神经保护作用
- 批准号:
10568150 - 财政年份:2023
- 资助金额:
$ 37.27万 - 项目类别:
IND-enabling studies for cell therapy in Parkinson's disease
帕金森病细胞疗法的 IND 研究
- 批准号:
10760861 - 财政年份:2023
- 资助金额:
$ 37.27万 - 项目类别: